医学分子生物学杂志 ›› 2026, Vol. 23 ›› Issue (2): 164-170.doi: 10.3870/j.issn.1672-8009.2026.02.008

• 论著 • 上一篇    下一篇

MMP2调节高级别浆液性卵巢癌细胞对PARP抑制剂Olaparib敏感性的机制研究

邵萍, 邓青春   

  1. 海南医科大学第二附属医院妇科 海口市,570102
  • 收稿日期:2025-04-21 出版日期:2026-03-31 发布日期:2026-04-03
  • 通讯作者: 邓青春(E-mail:qingchun0503@163.com)
  • 基金资助:
    海南省自然科学基金高层次人才项目(No.821RC712)

Effect of MMP2 Expression on Cell Sensitivity to PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer Cells

SHAO Ping, DENG Qingchun   

  1. Department of Gynecology,the Second Affiliated Hospital of Hainan Medical University,Haikou,570102,China
  • Received:2025-04-21 Online:2026-03-31 Published:2026-04-03
  • Contact: DENG Qingchun(E-mail:qingchun0503@163.com)
  • Supported by:
    High-level Talent Program of Natural Science Foundation in Hunan(No.821RC712)

摘要: 目的 探讨基质金属蛋白酶2(matrix metalloproteinase-2,MMP2)对高级别浆液性卵巢癌(high-grade serous ovarian cancer,HGSOC)细胞聚-ADP核糖聚合酶抑制剂(poly-ADP ribose polymerase inhibitor,PARPi)敏感性的影响及机制。方法 培养HGSOC细胞株HeyA8,分为对照组、sh-NC组、sh-MMP2组,RT-qPCR和蛋白质印迹检测MMP2表达,CCK-8法检测不同浓度奥拉帕尼(olaparib)处理下细胞存活率。再将HeyA8细胞分为sh-NC组、sh-MMP2组、sh-NC+PARPi组、sh-MMP2+PARPi组,细胞划痕实验、Annexin V-FITC/PI法、Hochest 33258染色分别检测细胞迁移与凋亡,蛋白质印迹测定血管内皮生长因子(vascular endothelial growth factor,VEGF)/磷脂酰肌醇3-激酶(phosphoinositide 3-kinase,PI3K)/蛋白激酶B(protein kinase B,Akt)信号通路相关蛋白表达。结果 与对照组、sh-NC组比较,sh-MMP2组HeyA8细胞中MMP2 mRNA及蛋白相对表达量下调,Olaparib处理后的细胞存活率降低(P<0.05)。与sh-NC组比较,sh-MMP2组细胞划痕愈合率降低,凋亡率增加,可见核浓缩、碎裂的凋亡形态,血管内皮生长因子A(vascular endothelial growth factor A,VEGFA)、血管内皮细胞生长因子受体2(vascular endothelial growth factor receptor 2,VEGFR2)、磷酸化PI3K(Tyr458)[p-PI3K(Tyr458)]、磷酸化Akt(Ser473)[p-Akt(Ser473)]蛋白相对表达水平均下调(P<0.05);与sh-NC+PARPi组比较,sh-MMP2+PARPi组细胞划痕愈合率降低,凋亡率增加,核浓缩、碎裂的凋亡细胞更多,VEGFA、VEGFR2、p-PI3K(Tyr458)、p-Akt(Ser473)蛋白相对表达水平也均下调(P<0.05)。结论 沉默MMP2表达能够促进PARPi诱导的HGSOC细胞凋亡,增加PARPi敏感性。

关键词: 高级别浆液性卵巢癌, 基质金属蛋白酶2, 奥拉帕尼, 药物敏感性, 血管内皮生长因子/磷脂酰肌醇3-激酶/蛋白激酶B通路

Abstract: Objective To investigate the effect of matrix metalloproteinase 2(MMP2)on the sensitivity of poly-ADP ribose polymerase inhibitor(PARPi)in high-grade serous ovarian cancer(HGSOC)cells and the underlying mechanism.Methods The HGSOC cell line HeyA8 cells were divided into 3 groups:control group,sh-NC group,sh-MMP2 group.RT-qPCR and Western blotting were used to detect the expression of MMP2.CCK-8 method was used to detect the cell survival rate under different concentrations of Olaparib.Then HeyA8 cells were divided into 4 groups:sh-NC group,sh-MMP2 group,sh-NC+PARPi group,sh-MMP2+PARPi group.Wound-healing assay,Annexin V-FITC/PI method and Hochest 33258 staining were used to detect cell migration and apoptosis,respectively.Western blotting was used to determine the expression levels of proteins related to the vascular endothelial growth factor(VEGF)/phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt).Results Compared with those in the control group and the sh-NC group,the relative expression levels of MMP2 mRNA and protein of HeyA8 cells in the sh-MMP2 group were downregulated,and the cell survival rate after Olaparib treatment was reduced(P<0.05).Compared with those in the sh-NC group,the wound-healing rate of HeyA8 cells in the sh-MMP2 group was decreased,the apoptosis rate was increased,nuclear condensation and fragmentation of apoptotic cells were observed,the relative protein expression levels of vascular endothelial growth factor A(VEGFA),vascular endothelial growth factor receptor 2(VEGFR-2),phosphorylated PI3K(Tyr458)[p-PI3K(Tyr458)]and phosphorylated Akt(Ser473)[p-Akt(Ser473)]were all downregulated(P<0.05).Compared with those in the sh-NC+PARPi group,the wound-healing rate of HeyA8 cells in the sh-MMP2+PARPi group was decreased,the apoptosis rate was increased,more apoptotic cells with nuclear condensation and fragmentation were observed,the relative protein expression levels of VEGFA,VEGFR2,p-PI3K(Tyr458)and p-Akt(Ser473)were downregulated(P<0.05).Conclusion Silencing MMP2 expression can promote PARPi-induced apoptosis in HGSOC cells,and increase PARPi sensitivity.

Key words: high-grade serous ovarian cancer, matrix metalloproteinase 2, olaparib, drug sensitivity, vascular endothelial growth factor/phosphatidylinositol 3-kinase/protein kinase B pathway

中图分类号: